 |
|
Prevention of Lung Cancer: Future Perspective with Natural Compounds.
Johann C Brandes, Ruhul Amin, Fadlo Khuri, Dong Moon Shin
Tuberc Respir Dis. 2010;69(1):1-15. Published online 2010 Jul 1 DOI: https://doi.org/10.4046/trd.2010.69.1.1
|
|
Citations to this article as recorded by
 Structure-Activity Relationship Insight of Naturally Occurring Bioactive
Molecules and Their Derivatives Against Non-Small Cell Lung
Cancer: A Comprehensive Review
Subham Das, Shubham Roy, Seikh Batin Rahaman, Saleem Akbar, Bahar Ahmed, Debojyoti Halder, Anu Kunnath Ramachandran, Alex Joseph
Current Medicinal Chemistry.2022; 29(39): 6030. CrossRef Lung Cancers and the Roles of Natural Compounds as Potential Chemotherapeutic and Chemopreventive Agents
Omchit Surien, Ahmad Rohi Ghazali, Siti Fathiah Masre
Biomedical and Pharmacology Journal.2019; 12(1): 85. CrossRef Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis
Bing Wang, Zhanjie Zuo, Fang Li, Kun Yang, Minjun Du, Yushun Gao
Open Medicine.2017; 12(1): 86. CrossRef Smoking cessation interventions for lung cancer patients
Kristin V Carson, Zafar A Usmani, Thomas A Robertson, Satya Mysore, Malcolm P Brinn
Lung Cancer Management.2013; 2(1): 61. CrossRef Le sevrage tabagique
G. Peiffer, M. Underner, J. Perriot, N. Paillot, F. Renolleau
Revue des Maladies Respiratoires Actualités.2013; 5(5): e5. CrossRef
|